Juravinski Cancer Centre is inviting applications for Investigational New Drug Fellowship in Medical Oncology field. This fellowship award open to either Canadian and overseas scholars. Interesting salary will be given to the fellows for maximum two years duration. To apply, the application packet must be submitted no later than 1 July 2017.
The Department of Oncology located at the Juravinski Cancer Centre is offering a 1-2 year Investigational New Drug (IND) Fellowship. The Juravinski Cancer Centre (JCC) in Hamilton, Ontario, Canada is one of the five largest cancer centres in North America, and has evolved to become one of the leading Canadian centres in the study of Investigational New Drugs (IND). In addition to being the top accruer to IND studies to the National Institute of Canada Clinical Trials Group (NCIC-CTG) over the past five years, the centre has also been actively involved with industry-sponsored IND studies.
One best fellow will receive benefit of salary at the PGY6 level.
Level and Area of Studies
Non-degree program in Medical Oncology studies.
Place of Study
The program can be taken in Canada.
Eligibility and Criteria
To be eligible, the applicants must have completed specialty in Medical Oncology and have CPSO licensing to practice in the Province of Ontario.
Canadian and overseas students are welcome to apply.
Please the detailed instruction at the website and application link below.
1 July 2017.